Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 91-100 , April 2007

Ex vivo Production of Human Red Blood Cells From Hematopoietic Stem Cells: What Is the Future in Transfusion?

  • Luc Douay

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Luc Douay, Hopital Armand Trousseau, Service d'Hematologie Biologique, 26 Avenue du Docteur Arnold Netter, 75012 Paris, France.
    • ,
  • Georges Andreu

References 

  1. Robertson OH. Transfusion with preserved red blood cells. Br Med J. 1918;1:691–695
  2. Loutit JF, Mollisson PL. Advantages of a disodium-citrate-glocose mixture as a blood preservative. Br Med J. 1943;2:744–745
  3. Walter CW, Murphy WP. A closed gravity technique for the preservation of whole blood in ACD solution utilizing plastic equipment. Surg Gynecol Obstet. 1952;94:687–692
  4. Guide to the preparation, use and quality assurance of blood components, recommendation N° R (95) 15. ed 12. Counsil of Europe Publishing; 2006;
  5. Creteur J, Sibbald W, Vincent JL. Hemoglobin solutions—Not just red blood cell substitutes. Crit Care Med. 2000;28:3025–3034
  6. Spahn DR, Waschke KF, Standl T, et al. Use of perflubron emulsion to decrease allogenic blood transfusion in high-blood-loss non-cardiac surgery: Results of a European phase 3 study. Anesthesiology. 2002;97:1338–1349
  7. Kruskall MS, AuBuchon JP, Anthony KY, et al. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion. 2000;40,11:1290–1298
  8. Nacharaju P, Boctor F, Manjoula B, et al. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: An approach to mask A, B, and D antigens to generate universal red blood cells. Transfusion. 2005;45:374–383
  9. Douay L. Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells: Review. J Haematother Stem Cell Res. 2001;341–346
  10. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147
  11. Chen CY, Pajak L, Tamburlin J, et al. The effect of proteasome inhibitors on mammalian erythroid terminal differentiation. Exp Hematol. 2002;30:634–639
  12. Neildez-Nguyen TM, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol. 2002;20:467–472
  13. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;81:2844–2853
  14. Friedenstein AJ, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2:83–92
  15. Koller MR, Oxender M, Jensen TC, et al. Direct contact between CD34+lin− cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production. Exp Hematol. 1999;27:734–741
  16. Lemischka IR. Microenvironmental regulation of hematopoietic stem cells. Stem Cells. 1997;15(Suppl 1):63–68
  17. Verfaillie CM. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood. 1993;82:2045–2053
  18. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23,1:69–74
  19. Lichtman MA. The ultrastructure of the hemopoietic environment of the marrow: A review. Exp Hematol. 1981;9:391–410
  20. Propper RD, Button LN, Nathan DG. New approaches to the transfusion management of thalassemia. Blood. 1980;55:55–60
  21. Marcus RE, Wonke B, Bantock HM. A prospective trial of young red cells in 48 patients with transfusion-dependent thalassemia. Br J Haematol. 1985;60:153–159
  22. Mollison PL. Methods of determining the post transfusion survival of stored red cells. Transfusion. 1984;24:93–96
  23. Card RT. Red cell membrane changes during storage. Transfus Med Rev. 1988;2:40–47
  24. Heaton A, Keegan T, Holme S. In vivo regeneration of red cell 2,3 diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J Haematol. 1989;71:131–136
  25. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409–417
  26. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 1999;178:570–572
  27. Basran S, Frumento RJ, Cohen A, et al. The association between duration of storage of transused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg. 2006;103:15–20
  28. Andreu G, Morel P, Forestier F, et al. Haemovigilance network in France: Organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 2002;42:1356–1364
  29. Kopko PM, Popovsky MA, MacKenzie MR, et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41:1244–1248
  30. Silliman C, Thurman G, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating factor receptor. Vox Sang. 1992;63:133–136
  31. Ropars C, Jesseire B, Avenard G, et al. Improved oxygen delivery to tissues and iron chelator transport through the use of lysed and resealed red blood cells: A new perspective on Cooley's anemia therapy. Ann N Y Acad Sci. 1985;445:304–315
  32. Van der Poel C, Janssen M. The collection, testing and use of blood and blood products in Europe in 2003. In: European Health Committee (CDSP) 56th Meeting Strasbourg. 2004;p. 16–17
  33. National Blood Data Resources Center . Comprehensive report on blood collection and transfusion in the United States in. National Blood Data Resources Center. Bethesda (MD): AABB Press; 2001;
  34. Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. Bureau of the census, current population reports, P25-1130, US. Washington (DC): U.S. Government Printing Office; 1996;
  35. Robert-Bobée I. Projections de population pour la France métropolitaine à l'horizon 2050. Paris: INSEE Première; 2006;
  36. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2002 incidence and mortality. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005;

PII: S0887-7963(06)00093-9

doi: 10.1016/j.tmrv.2006.11.004

Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 91-100 , April 2007

Article Tools

* Image Usage & Resolution